Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-20

Clinical Trial Update: CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CO2-augmented phenylephrine with phenylephrine alone in patients with progressive acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CO2 Phenylephrine
  • Phenylephrine (phenylephrine)

Snippet

Sponsor: Yonsei University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING